Literature DB >> 22684398

Analysis of perioperative clinical features and complications after orthopaedic surgery in rheumatoid arthritis patients treated with tocilizumab in a real-world setting: results from the multicentre TOcilizumab in Perioperative Period (TOPP) study.

Shigeki Momohara1, Jun Hashimoto, Hideki Tsuboi, Hisaaki Miyahara, Natsuko Nakagawa, Atsushi Kaneko, Naoki Kondo, Hiroaki Matsuno, Takahiko Wada, Tohgo Nonaka, Katsuaki Kanbe, Haruki Takagi, Akira Murasawa, Tsukasa Matsubara, Toru Suguro.   

Abstract

OBJECTIVE: To evaluate perioperative changes in rheumatoid arthritis (RA) patients treated with tocilizumab.
METHODS: We collected RA cases with tocilizumab and orthopaedic surgery from 1999 to 2010. Incidences of postoperative infections, delayed wound healing, and RA symptom flare-ups were extracted from the data for comparison with patients without these postoperative events. We also evaluated the changes in C-reactive protein (CRP) and body temperature in patients without postoperative complications with normal CRP before surgery, i.e., patients without postoperative events in whom the tocilizumab level was maintained, for each duration to discontinuation before surgery.
RESULTS: A total of 161 cases (n = 122) were collected. The patients had mean age of 56.9 years, and mean disease duration of 12.8 years at operation. Joint replacement surgery was performed in 89 cases. Three patients had postoperative infections (two superficial and one organ/space surgical-site infection), 20 had delayed wound healing, and 36 had RA symptom flare-ups. Delayed wound healing occurred most commonly in patients who underwent spinal surgery (P = 0.0061, versus patients without delayed wound healing). CRP levels were high when tocilizumab was restarted in patients with RA symptom flare-ups (P = 0.0010, versus patients without RA symptom flare-ups). Increased postoperative CRP was observed in patients without postoperative events when the duration from final tocilizumab infusion to surgery was long. The changes in body temperature showed a similar trend to CRP.
CONCLUSIONS: Although it has been demonstrated that infection rates in patients treated with tocilizumab are by no means high, incidence of delayed wound healing was significantly higher in cases with surgical interventions such as foot and spinal surgeries. Many patients treated with tocilizumab remained in a normal range of CRP even during the perioperative period. For prevention of perioperative complications, observation of postoperative conditions and surgical wounds, and subjective symptoms of patients are considered important.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22684398     DOI: 10.1007/s10165-012-0683-0

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  12 in total

1.  [Recommendations of the German Society for Rheumatology on the perioperative approach under therapy with DMARDs and biologicals in inflammatory rheumatic diseases].

Authors:  K Krüger; K Albrecht; S Rehart; R Scholz
Journal:  Z Rheumatol       Date:  2014-02       Impact factor: 1.372

2.  Late-onset deep surgical-site infection after posterior lumbar interbody fusion in a patient treated with tocilizumab; unusual changes in inflammatory markers.

Authors:  Takahiro Makino; Takashi Kaito; Hideki Tsuboi; Hiroyasu Fujiwara; Kazuo Yonenobu
Journal:  Eur Spine J       Date:  2014-04-24       Impact factor: 3.134

Review 3.  Perioperative management of immunosuppression in patients with rheumatoid arthritis.

Authors:  Michael D George; Joshua F Baker
Journal:  Curr Opin Rheumatol       Date:  2019-05       Impact factor: 5.006

Review 4.  Prevention of Infection in the Perioperative Setting in Patients with Rheumatic Disease Treated with Immunosuppression.

Authors:  Joshua F Baker; Michael D George
Journal:  Curr Rheumatol Rep       Date:  2019-03-08       Impact factor: 4.592

Review 5.  Optimizing perioperative outcomes for older patients with rheumatoid arthritis undergoing arthroplasty: emphasis on medication management.

Authors:  Susan M Goodman
Journal:  Drugs Aging       Date:  2015-05       Impact factor: 3.923

Review 6.  Perioperative infection in the patient with rheumatic disease.

Authors:  Andy O Miller; Barry D Brause
Journal:  Curr Rheumatol Rep       Date:  2013-12       Impact factor: 4.592

7.  Periprosthetic joint infection in patients with inflammatory joint disease: a review of risk factors and current approaches to diagnosis and management.

Authors:  Todd A Morrison; Mark Figgie; Andy O Miller; Susan M Goodman
Journal:  HSS J       Date:  2013-07-03

8.  Delayed wound healing and postoperative surgical site infections in patients with rheumatoid arthritis treated with or without biological disease-modifying antirheumatic drugs.

Authors:  Masahiro Tada; Kentaro Inui; Yuko Sugioka; Kenji Mamoto; Tadashi Okano; Takuya Kinoshita; Noriaki Hidaka; Tatsuya Koike
Journal:  Clin Rheumatol       Date:  2016-04-29       Impact factor: 2.980

Review 9.  Perioperative management of the patient with rheumatoid arthritis.

Authors:  Megan L Krause; Eric L Matteson
Journal:  World J Orthop       Date:  2014-07-18

Review 10.  [Periprosthetic infections in systemic inflammatory rheumatic disease. Review article on diagnostics and therapy].

Authors:  U Illgner; A Uekötter; L Bause
Journal:  Z Rheumatol       Date:  2014-06       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.